← Open Payments lookup

EMILY MAASS: Open Payments

NPI 1659925600 · RED OAK, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$580 in 35 payments from 13 companies in 2025. Trend: 2023 $639 · 2024 $838 · 2025 $580

Food & beverage: $580
CompanyPaymentsAmount
Lilly USA, LLC13$160
Novo Nordisk Inc4$72
PFIZER INC.3$62
Novartis Pharmaceuticals Corporation3$54
AstraZeneca Pharmaceuticals LP2$38
E.R. Squibb & Sons, L.L.C.2$35
Actelion Pharmaceuticals US, Inc.1$30
Phathom Pharmaceuticals, Inc.2$29
Lundbeck LLC1$27
Otsuka America Pharmaceutical, Inc.1$25

Products named: MOUNJARO, LEQVIO, REXULTI, Ozempic, PREVNAR 20, CAMZYOS, OPSUMIT, VOQUEZNA.

Industry payments across IA — which companies pay providers there.